Kenneth Horton
Conseiller Juridique Général chez SENSEONICS HOLDINGS, INC.
Fortune : 813 924 $ au 30/04/2024
Profil
Kenneth L.
Horton is currently the General Counsel at Senseonics Holdings, Inc. He previously served as the Chairman at Lumira Capital (USA) Corp.
From 2012 to 2015, he was the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. Kenneth also held the position of VP-Acquisitions, Ventures & General Counsel at Revvity, Inc. Prior to that, he was the EVP-Corporate Development & General Counsel at Nordion (Canada), Inc. from 2005 to 2012.
Mr. Horton completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 1 947 186 ( 0,37% ) | 813 924 $ | 30/04/2024 |
Postes actifs de Kenneth Horton
| Sociétés | Poste | Début |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | Conseiller Juridique Général | 01/10/2017 |
Anciens postes connus de Kenneth Horton
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 20/01/2015 |
| NORDION INC | Conseiller Juridique Général | 01/01/2012 |
| Lumira Capital (USA) Corp. | Président | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Formation de Kenneth Horton
| Dartmouth College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| REVVITY, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
| Lumira Capital (USA) Corp. |
